Cargando…

A feasibility study of avoiding positive calcium balance and parathyroid hormone increase in patients on peritoneal dialysis

BACKGROUND: The effect of the dialysate calcium concentration (D[Ca]) on mineral and bone metabolism in patients on peritoneal dialysis (PD) is overlooked. D[Ca] of 1.75 mmol/L is still prescribed to many patients on PD around the world. Previous studies on the effects of reducing D[Ca] have been ca...

Descripción completa

Detalles Bibliográficos
Autores principales:	Piraciaba, Maria Clara Teixeira, Cordeiro, Lilian, Guimarães, Erica Adelina, Abensur, Hugo, Pereira, Benedito Jorge, Jorgetti, Vanda, Moysés, Rosa Maria Affonso, Elias, Rosilene Motta
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2022
Materias:	Full Length Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9547188/ https://www.ncbi.nlm.nih.gov/pubmed/36217349 http://dx.doi.org/10.1016/j.bonr.2022.101625

Ejemplares similares

A randomized clinical trial to evaluate the effects of icodextrin on left ventricular mass index in peritoneal dialysis
por: Cordeiro, Lilian, et al.
Publicado: (2022)

Chronic kidney disease is a main confounding factor for 25-vitamin D measurement
por: Machado, Hanna Karla Andrade Guapyassú, et al.
Publicado: (2019)

Ankle-Brachial Index: A Simple Way to Predict Mortality among Patients on Hemodialysis - A Prospective Study
por: Jimenez, Zaida Noemy Cabrera, et al.
Publicado: (2012)

Nephrology picture: bone loss due to absence of adequate therapy for severe secondary hyperparathyroidism
por: Duque, Eduardo J., et al.
Publicado: (2022)

A prospective study of the influence of the skeleton on calcium mass transfer during hemodialysis
por: Goldenstein, Patricia Taschner, et al.
Publicado: (2018)

Cardiovascular mortality in peritoneal dialysis: the impact of mineral disorders
por: Truyts, César, et al.
Publicado: (2021)

Parathyroid Hormone: A Uremic Toxin
por: Duque, Eduardo J., et al.
Publicado: (2020)

Parathyroidectomy Improves Restless Leg Syndrome in Patients on Hemodialysis
por: Santos, Roberto Sávio Silva, et al.
Publicado: (2016)

Parathyroidectomy Improves Survival In Patients with Severe Hyperparathyroidism: A Comparative Study
por: Goldenstein, Patricia Taschner, et al.
Publicado: (2013)

The Protein-Independent Role of Phosphate in the Progression of Chronic Kidney Disease
por: Duayer, Irene Faria, et al.
Publicado: (2021)

Avoidance of Difficulties with Peritoneal Dialysis
por: Goldsmith, H.J.
Publicado: (1980)

Kidneys also "speak Portuguese"
por: Santos, Iara da Silva, et al.
Publicado: (2021)

The disparity of measuring bone mineral content using bioimpedance and dual-energy absorptiometry in the context of hyperparathyroidism
por: Crispilho, Shirley Ferraz, et al.
Publicado: (2020)

Chronic kidney disease patients who smoke have higher serum phosphorus
por: dos Santos, Geuza Dutra, et al.
Publicado: (2018)

Protective measures against ultrafiltration failure in peritoneal dialysis patients
por: Aguirre, Anna Rita, et al.
Publicado: (2011)

Predictive Factors of One-Year Mortality in a Cohort of Patients Undergoing Urgent-Start Hemodialysis
por: Magalhães, Luciene P., et al.
Publicado: (2017)

Peritoneal Dialysis–Associated Peritonitis: Suggestions for Management and Mistakes to Avoid
por: Al Sahlawi, Muthana, et al.
Publicado: (2020)

Renal osteodystrophy in the obesity era: Is metabolic syndrome relevant?
por: Da Silva Martins, Janaina, et al.
Publicado: (2017)

Hungry bone syndrome in peritoneal dialysis patients after parathyroid surgery
por: Yeh, Heng, et al.
Publicado: (2023)

Aberrant serum parathyroid hormone, calcium, and phosphorus as risk factors for peritonitis in peritoneal dialysis patients
por: Liao, Chia-Te, et al.
Publicado: (2021)

Serum sclerostin is an independent predictor of mortality in hemodialysis patients
por: Gonçalves, Flávia Letícia Carvalho, et al.
Publicado: (2014)

25-vitamin D reduces inflammation in uremic environment
por: Brito, Rodrigo Barbosa de Oliveira, et al.
Publicado: (2020)

Author Correction: Aberrant serum parathyroid hormone, calcium, and phosphorus as risk factors for peritonitis in peritoneal dialysis patients
por: Liao, Chia-Te, et al.
Publicado: (2022)

Fluid overload after coronary artery bypass graft in patients on maintenance hemodialysis is associated with prolonged time on mechanical ventilation
por: da Silva, Sirlei Cristina, et al.
Publicado: (2020)

High prevalence of biochemical disturbances of chronic kidney disease - mineral and bone disorders (CKD-MBD) in a nation-wide peritoneal dialysis cohort: are guideline goals too hard to achieve?
por: Weissheimer, Rafael, et al.
Publicado: (2021)

Effects of parathyroid hormone and vitamin D supplementation on stroke among patients receiving peritoneal dialysis
por: You, Xiaohan, et al.
Publicado: (2020)

Low serum parathyroid hormone is a risk factor for peritonitis episodes in incident peritoneal dialysis patients: a retrospective study
por: Yang, Yuqi, et al.
Publicado: (2021)

Peritoneal dialysis: why not?
por: Andreoli, Maria Claudia Cruz, et al.
Publicado: (2023)

The impact of peritoneal dialysis-related peritonitis on mortality in peritoneal dialysis patients
por: Ye, Hongjian, et al.
Publicado: (2017)

Peritoneal dialysis: update on patient survival
por: Teixeira, J. Pedro, et al.
Publicado: (2015)

Relationship between the Serum Parathyroid Hormone and Magnesium Levels in Continuous Ambulatory Peritoneal Dialysis (CAPD) Patients using Low-magnesium Peritoneal Dialysate
por: Cho, Min Seok, et al.
Publicado: (2002)

Differentially expressed miR-3680-5p is associated with parathyroid hormone regulation in peritoneal dialysis patients
por: Jeong, Sohyun, et al.
Publicado: (2017)

Depression in hemodialysis patients: the role of dialysis shift
por: Teles, Flavio, et al.
Publicado: (2014)

Taurolidine Peritoneal Dialysis Catheter Lock to Treat Relapsing Peritoneal Dialysis Peritonitis
por: Alvarez Nadal, Marta, et al.
Publicado: (2020)

Peritoneal Dialysis
por: Pyper, R. A.
Publicado: (1948)

Peritoneal Dialysis
por: Taskapan, Hulya, et al.
Publicado: (2011)

Nebivolol, a β1-adrenergic blocker, protects from peritoneal membrane damage induced during peritoneal dialysis
por: Liappas, Georgios, et al.
Publicado: (2016)

Modelling competing risks in nephrology research: an example in peritoneal dialysis
por: Teixeira, Laetitia, et al.
Publicado: (2013)

Correction: Nebivolol, a β(1)-adrenergic blocker, protects from peritoneal membrane damage induced during peritoneal dialysis
por: Liappas, Georgios, et al.
Publicado: (2017)

Ultrasonographic Evaluation of Parathyroid Hyperplasia in Dialysis Patients
por: Pavlovic, Drasko, et al.
Publicado: (2006)

Cannot write session to /tmp/vufind_sessions/sess_u3lr3plemlom2u9gqgk5468e3p